Vilon Peptides 20mg 10vials 1kits

Description

High purity Vilon Research Peptide | Synthetic Short Bioregulatory Peptide (Cytogen)

Product Specifications

• Amino Acid Sequence: L-Lysyl-L-Glutamic Acid (Lys-Glu / KE)
• CAS Number: 82046-63-7
• Molecular Formula: C11H21N3O5
• Molecular Weight: 275.30 g/mol
• Purity: >99.0% via HPLC-UV analysis
• Appearance: Sterile white lyophilized powder cake

How It Works

The biochemical activity of Vilon is governed by its unique capability to pass structural biological boundaries and modulate DNA-protein architecture within targeted cell cores. In the first phase, the low-molecular-weight dipeptide permeates the nuclear envelope via simple passive diffusion without requiring energy-dependent macromolecular transporter complexes. This defines the first semantic triple: [Vilon penetrates the lymphocyte nuclear envelope]. Secondly, the negatively charged carboxyl groups on the glutamic acid residue dock securely into the major grooves of double-stranded DNA to alter local nucleoprotein charges. This establishes the second triple: [Peptide binding decondenses transcriptionally silent heterochromatin]. Finally, this targeted spatial unwinding exposes hidden promoter regions, initiating immediate gene activation. This forms the third triple: [Chromatin modification upregulates interleukin-2 gene transcription]. Quantitatively, Vilon exhibits a brief systemic plasma half-life of approximately 15 minutes ($t_{1/2} = 15.0 pm 3.0$ min) driven by localized plasma aminopeptidase cleavage velocities, but the downstream transcriptional modifications maintain a prolonged cellular footprint for up to 48 hours. In comparative studies, Vilon is strictly distinguished from the complex peptide matrix Thymalin; while Thymalin functions as a non-standardized animal-derived thymic extract providing broad, zinc-dependent systemic immune-modulatory signals, Vilon represents a single, highly defined synthetic active isolate that specifically targets immune cell restoration and localized cytokine pathways.

Overview

Vilon is a synthetic tissue-specific dipeptide developed to regulate structural and transcriptional dynamics within mammalian immune lineages. [Vilon upregulates lymphocyte differentiation pathways]. This highly pure short bioregulator serves as a primary research benchmark for investigating heterochromatin decondensation, localized lymphocyte preservation, and the deceleration of age-dependent immune involution pathways under severe oxidative or chemical duress. Its compact molecular layout allows for direct nuclear envelope penetration and chromatin interaction without severe steric interference or structural destabilization.

Known Effects

• Optimization of Lymphocyte Proliferation: Users in research models report a pronounced optimization of T-cell populations and restored expression of cellular differentiation markers.
• Immune Cellular Activation: Published research indicates a marked optimization of macrophage activity and enhanced phagocytosis kinetics under stress.
• Epigenetic DNA Remodeling: Per experimental records, research models show that the dipeptide shifts highly condensed, silent heterochromatin states toward transcriptionally active configurations.
• Attenuated Cellular Senescence: Multiple research groups note noticeable preservation of thymic tissue architecture and cell viability during chronic environmental duress.
• Enhanced Cellular Resilience: Research models have observed stabilized cell cycle parameters when exposed to intense oxidative or chemical stressors.

Key Points:
Vilon represents a premier, targeted short peptide research tool for investigating the direct epigenetic regulation of nuclear structural factors and the molecular pathways of immune restoration.

Frequently Asked Questions

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use.